Gilead Sciences Inc (NASDAQ: GILD)
DRUGS - Biotechnology
Health Care
Stock price data as of
Closing price: $144.99
-
Support level$136.23
-
Resistance levelN/A
-
Beta0.3
-
RSI (14-day)41.2
- Volatility is forecast to fall over the next month.
- GILD is above its 200-day moving average, providing a measure of support for long positions.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $96.91 | $155.80 | 84.9% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $122.21 | $139.90 | $148.47 | $146.65 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week7.2%
-
In the next month14.6%
-
In the next year56.6%
| Period | Value |
|---|---|
| Historical (5 year) | 23.9% |
| Last month | 30.1% |
| Current estimate | 26.5% |
| Next month forecast | 25.8% |